Brief: Atara Biotherapeutics Provides Regulatory And Business Update On Ebvallo™ (Tabelecleucel)

Atara Biotherapeutics

12/01/2026 13:05

Jan 12 (Reuters) - Atara Biotherapeutics Inc ATRA.O:

ATARA BIOTHERAPEUTICS PROVIDES REGULATORY AND BUSINESS UPDATE ON EBVALLO™ (TABELECLEUCEL)

ATARA BIOTHERAPEUTICS INC: U.S. FOOD AND DRUG ADMINISTRATION HAS ISSUED A COMPLETE RESPONSE LETTER (CRL)

ATARA BIOTHERAPEUTICS INC - FDA ISSUES COMPLETE RESPONSE LETTER FOR EBVALLO BLA

ATARA BIOTHERAPEUTICS INC - FDA UNABLE TO APPROVE EBVALLO BLA IN PRESENT FORM

Source text: ID:nBw3LZs1ca

Further company coverage: ATRA.O

 ((Reuters.Briefs@thomsonreuters.com;))